{"schema":"hottub-news/story/v1","story":"st_a4xi5ruasetu5r62ptea","title":"Eli Lilly: Vårt piller är bättre än Novos","title_en":"Eli Lilly: Our pill is better than Novos","outlets":1,"brief":null,"page":"https://hottub.news/stories/eli-lilly-our-pill-is-better-than-novos-a4xi5ruase","count":1,"items":[{"id":"n_a4xi5ruasetu5r62ptea","seq":612129,"kind":"article","title":"Eli Lilly: Vårt piller är bättre än Novos","title_en":"Eli Lilly: Our pill is better than Novos","url":"https://www.di.se/live/eli-lilly-vart-piller-ar-battre-an-novos","summary":"Amerikanska Eli Lilly har under diabeteskongressen EASD (European Association för the Study of Diabetes) presenterat data från en indirekt jämförelse mellan bolagets orala fetmaläkemedel Fundayo, som visade en signifikant större viktnedgång och bättre blodsockerkontroll än det konkurrerande läkemedlet Wegovy-pillret (oralt semaglutid) från danska Novo.","published":"2026-09-29T07:44:52Z","seen":"2026-09-29T08:12:22Z","lang":"sv","country":"SE","source":{"id":"kite-di-se-755352","name":"di.se","domain":"di.se","outlet":{"wikidata":"Q734293","name":"Dagens Industri","type":"newspaper","designations":["newspaper"]}},"via":"kite-di-se-755352","authors":["Nyhetsbyrån Direkt"],"entities":[{"id":"Q2984214","name":"Eli Lilly","type":"org"}],"image":"https://static.bonniernews.se/ba/4cb09c52-9d36-4841-acd0-73b32a1a9078.png?width=600","story":"st_a4xi5ruasetu5r62ptea","category":"health","category_p":0.4300000071525574,"sentiment":"positive","tone":0.5299999713897705,"political":0.09000000357627869}]}